Amy Herr
Förmögenhet: 148 838 $ per 2026-05-31
Förmögenhet: 148 838 $ per 2026-05-31
Amy E.
Herr is the founder of Zephyrus Biosciences, Inc. (2013).
Dr. Herr is an Independent Director at Bio-Techne Corp.
since 2025.
Formerly, Vice President at Chan Zuckerberg Biohub.
Education includes a doctorate from Stanford University and an undergraduate degree from California Institute of Technology.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-08 | 2 880 ( 0 % ) | 148 838 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| BIO-TECHNE CORPORATION | Direktör/Styrelseledamot | 2025-01-01 |
| Företag | Position | Slut |
|---|---|---|
Chan Zuckerberg Biohub
Chan Zuckerberg Biohub Packaged SoftwareTechnology Services Develops technology for medical researcher | Företagsledare/Principal | - |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Provides tools for protein analysis at the single cell level | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Bio-Techne Corp.
Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Provides tools for protein analysis at the single cell level | Health Technology |
Chan Zuckerberg Biohub
Chan Zuckerberg Biohub Packaged SoftwareTechnology Services Develops technology for medical researcher | Technology Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån